false
0001948864
0001948864
2025-12-31
2025-12-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 31, 2025
HEALTHY
CHOICE WELLNESS CORP.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-42274 |
|
88-4128927 |
| (State or Other Jurisdiction |
|
(Commission |
|
(I.R.S. Employer |
| of Incorporation) |
|
File Number) |
|
Identification No.) |
3800
N. 28th Way, #1
Hollywood,
Florida 33020
(Address
of Principal Executive Office) (Zip Code)
(888)
766-5351
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Class
A common stock |
|
HCWC |
|
NYSE
American |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| ITEM 5.07 |
Submission of Matters to a Vote
of Security Holders. |
On
December 31, 2025 the Company held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). According to the inspector
of elections, the stockholders present in person or by proxy at the Annual Meeting represented 10,409,200 shares of Class A common stock
(entitled to one vote per share) the Series A Convertible Preferred Stock (voting on as converted basis). At the Annual Meeting, the
Company’s stockholders voted on the matters set forth below.
Our
stockholders elected Gary Bodzin as Class I director of the Company to serve until the 2028 annual meeting of stockholders and until
such director’s successor has been duly elected and qualified. We set forth below the results of the stockholder vote for the director
nominee:
| Director |
|
Votes
For |
|
Votes
Withheld |
|
Broker
Non-Votes |
| Gary
Bodzin |
|
9,381,169 |
|
379,962 |
|
4,447,866 |
| 2. | Ratification
of Appointment of Independent Registered Public Accounting Firm |
Our
stockholders ratified the appointment of UHY LLP as our independent registered public accounting firm for our fiscal year ending December
31, 2025. We set forth below the results of the stockholder vote on this proposal:
| Votes
For |
|
Votes
Against |
|
Abstentions |
| 12,618,087 |
|
1,559,378 |
|
30,832 |
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits.
None.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
| |
HEALTHY
CHOICE WELLNESS CORP. |
| |
|
|
| Date: |
January 30,
2026 |
By: |
/s/ Jeffrey
E. Holman |
| |
|
Jeffrey E. Holman |
| |
|
Chief Executive Officer
|
